X4 Pharmaceuticals, Inc. (XFOR) Free cash flow 2022–2024
X4 Pharmaceuticals, Inc. (XFOR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$131.2MFY2024 · since FY2022: -$77.2M → -$131.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$131.2M | -35.9% |
| FY2023 | -$96.6M | -25.1% |
| FY2022 | -$77.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice